Invest Now
Products Pricing Partners Refer & Earn

Platforms

Trading Options

Platforms

Trading Options

Pricing

Trading & Investing

Calculators

Support

Learn

IPO

About Us

Partners

Refer & Earn

Open an account Login

Concord Drugs Ltd Share Price

₹ 0.00 0 (0%)

Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 0

 

Cons 7

Concord Drugs Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 35.69 up by 1.10%. The total volume of shares on NSE and BSE combined was 1,229 shares. Its total combined turnover was Rs 0.00 crores.

Concord Drugs Ltd Medium and Long Term Market Action

The stock price of Concord Drugs Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Concord Drugs Ltd Fundamentals

  • Market Cap (Cr): 35.9

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Concord Drugs Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Concord Drugs Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Concord Drugs Ltd

Data not available.

Concord Drugs Ltd FAQ's

What is Share Price of Concord Drugs Ltd?

What is the Market Cap of Concord Drugs Ltd?

What is PE Ratio of Concord Drugs Ltd?

What is PB Ratio of Concord Drugs Ltd?

What is the CAGR of Concord Drugs Ltd?

How to Buy Concord Drugs Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • No Data Available

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 2.31 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 77.82 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 439 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(10/03/2025)
Stock Valuation
Green line
100
0%
0% People are bullish about Concord Drugs Ltd
0%
0 % People are bearish about Concord Drugs Ltd

What is your opinion about this Stock?

Historical Data

Concord Drugs Ltd

₹ 0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now

      Open Free Trading & Demat Account

      +91